COM:ULTRAGENYX
Ultragenyx Pharmaceutical Inc.
- Stock
Last Close
46.02
22/11 21:00
Market Cap
3.85B
Beta: -
Volume Today
593.87K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 378.50K - | 3.91M 933.29% | 9.31M 137.93% | 12.30M 32.15% | 14.64M 19.05% | 21.50M 46.85% | 30.37M 41.25% | |||||
average payables | 1.32M - | 3.15M 138.68% | 3.90M 23.91% | 4.15M 6.50% | 7.13M 71.56% | 10.58M 48.50% | 12.57M 18.83% | 12.90M 2.58% | 15.03M 16.54% | 30.21M 100.96% | 42.69M 41.34% | |
average receivables | 2.59M - | 8.96M 246.33% | 22.79M 154.49% | 27.97M 22.71% | 25.76M 7.89% | 34.44M 33.68% | 56.92M 65.27% | |||||
book value per share | 1.72 - | 6.43 273.01% | 14.44 124.50% | 11.97 17.08% | 9.03 24.56% | 12.23 35.44% | 11.56 5.54% | 18.97 64.19% | 13.61 28.27% | 5.04 62.95% | 3.74 25.72% | |
capex per share | -0.01 - | -0.07 433.63% | -0.13 80.26% | -0.26 91.05% | -0.07 74.44% | -0.08 24.47% | -0.44 435.98% | -0.72 64.40% | -1.08 49.41% | -2.09 93.86% | -0.64 69.57% | |
capex to depreciation | -0.92 - | -3.14 242.74% | -3.58 13.95% | -2.98 16.89% | -0.48 83.89% | -0.21 56.49% | -2.91 1,293.96% | -3.58 23.14% | -5.52 54.18% | -8.02 45.26% | -1.80 77.58% | |
capex to operating cash flow | 0.01 - | 0.05 269.09% | 0.05 2.89% | 0.06 35.36% | 0.01 82.61% | 0.01 27.49% | 0.07 412.53% | 0.33 361.86% | 0.22 35.01% | 0.38 77.97% | 0.10 74.35% | |
capex to revenue | -76.60 - | -1.07 98.60% | -0.08 92.60% | -0.24 202.49% | -0.16 32.34% | -0.21 28.40% | -0.40 93.35% | -0.11 73.22% | ||||
cash per share | 1.84 - | 6.52 254.99% | 11.88 82.22% | 9.60 19.17% | 5.52 42.48% | 9.24 67.20% | 13.35 44.54% | 19.75 47.93% | 10.92 44.71% | 10.70 2.04% | 7.85 26.62% | |
days of inventory on hand | 276.31K - | 2.25K 99.19% | 467.84 79.21% | 777.05 66.09% | 370.08 52.37% | 344.97 6.79% | 274.25 20.50% | |||||
days payables outstanding | 3.24M - | 3.91K 99.88% | 521.53 86.66% | 769.60 47.57% | 390.77 49.23% | 557.73 42.73% | 340.01 39.04% | |||||
days sales outstanding | 722.73 - | 90.30 87.51% | 115.59 28.00% | 31.10 73.09% | 29.53 5.04% | 40.63 37.58% | 61.69 51.82% | |||||
debt to assets | 0.03 - | 0.03 15.87% | 0.03 0.58% | 0.02 25.85% | 0.03 41.63% | |||||||
debt to equity | 0.06 - | 0.04 26.17% | 0.05 8.89% | 0.09 97.01% | 0.16 74.88% | |||||||
dividend yield | 0.00 - | |||||||||||
earnings yield | -0.03 - | -0.05 65.94% | -0.04 25.54% | -0.09 150.31% | -0.15 73.71% | -0.09 40.50% | -0.17 82.53% | -0.02 86.71% | -0.08 259.55% | -0.22 174.23% | -0.17 21.02% | |
enterprise value | 1.22B - | 1.24B 1.40% | 4.03B 225.88% | 2.62B 34.98% | 1.87B 28.74% | 2.05B 9.76% | 2.02B 1.51% | 7.76B 284.07% | 5.44B 29.94% | 3.14B 42.27% | 3.35B 6.65% | |
enterprise value over ebitda | -35.25 - | -21.80 38.16% | -27.55 26.43% | -10.57 61.63% | -5.68 46.28% | -3.79 33.35% | -4.91 29.58% | -24.06 390.37% | -14.25 40.78% | -4.91 65.56% | -6.47 31.94% | |
ev to operating cash flow | -39.12 - | -27.73 29.12% | -38.05 37.25% | -16.29 57.19% | -7.36 54.81% | -7.06 4.11% | -5.85 17.14% | -58.67 903.27% | -16.05 72.65% | -8.25 48.61% | -7.05 14.54% | |
ev to sales | 19.72K - | 715.35 96.37% | 39.83 94.43% | 19.47 51.10% | 28.62 46.97% | 15.47 45.96% | 8.64 44.17% | 7.71 10.77% | ||||
free cash flow per share | -1.09 - | -1.63 49.59% | -3.02 85.37% | -4.32 43.37% | -6.05 39.81% | -5.92 2.08% | -6.54 10.54% | -2.89 55.76% | -6.07 109.84% | -7.53 24.00% | -7.09 5.84% | |
free cash flow yield | -0.03 - | -0.04 44.03% | -0.03 27.49% | -0.06 128.74% | -0.13 111.95% | -0.14 4.45% | -0.15 12.54% | -0.02 86.35% | -0.07 245.43% | -0.16 125.07% | -0.15 8.77% | |
graham net net | 1.51 - | 6.07 302.22% | 11.11 83.06% | 7.92 28.70% | 3.10 60.90% | 7.28 134.97% | 5.37 26.17% | 10.19 89.76% | 2.50 75.43% | -5.74 329.27% | -7.70 34.11% | |
graham number | 6.84 - | 17.35 153.54% | 35.86 106.73% | 40.90 14.06% | 38.03 7.02% | 33.06 13.08% | 43.02 30.14% | 36.18 15.90% | 45.28 25.16% | 33.88 25.18% | 26.36 22.19% | |
income quality | 0.89 - | 0.75 16.11% | 0.73 2.49% | 0.65 10.04% | 0.84 28.33% | 1.47 75.02% | 0.86 41.67% | 0.71 17.36% | 0.75 5.26% | 0.54 27.90% | 0.78 45.53% | |
intangibles to total assets | 0 - | 0 | 0 | 0 | 0.38 Infinity% | 0.24 36.32% | 0.15 36.71% | 0.10 34.68% | 0.12 15.36% | 0.13 14.99% | 0.14 6.78% | |
interest coverage | -373.72 - | -9.92 97.35% | -12.97 30.84% | -15.09 16.27% | -8.62 42.84% | |||||||
interest debt per share | 0.67 - | 1.34 98.81% | 1.05 21.40% | 1.07 1.34% | 1.48 39.11% | |||||||
inventory turnover | 0.00 - | 0.16 12,179.15% | 0.78 380.98% | 0.47 39.79% | 0.99 109.96% | 1.06 7.28% | 1.33 25.79% | |||||
invested capital | 0.06 - | 0.04 26.17% | 0.05 8.89% | 0.09 97.01% | 0.16 74.88% | |||||||
market cap | 1.23B - | 1.26B 2.76% | 4.13B 227.01% | 2.78B 32.55% | 1.97B 29.26% | 2.16B 9.92% | 2.42B 11.65% | 8.42B 248.57% | 5.70B 32.32% | 3.24B 43.18% | 3.52B 8.57% | |
net current asset value | 45.69M - | 174.47M 281.89% | 421.73M 141.73% | 431.46M 2.31% | 137.17M 68.21% | 411.72M 200.15% | 369.29M 10.31% | 690.12M 86.88% | 256.77M 62.79% | -309.05M 220.36% | -483.42M 56.42% | |
net debt to ebitda | 0.21 - | 0.43 99.73% | 0.64 49.24% | 0.65 1.62% | 0.31 52.98% | 0.21 31.45% | 0.96 360.00% | 2.06 114.18% | 0.70 66.25% | 0.16 77.23% | 0.33 108.01% | |
net income per share | -1.21 - | -2.08 72.34% | -3.96 90.36% | -6.21 56.89% | -7.12 14.59% | -3.97 44.22% | -7.12 79.30% | -3.07 56.92% | -6.70 118.41% | -10.12 51.09% | -8.25 18.48% | |
operating cash flow per share | -1.07 - | -1.55 44.58% | -2.88 85.62% | -4.07 41.14% | -5.98 47.04% | -5.84 2.37% | -6.10 4.58% | -2.17 64.40% | -5.00 129.90% | -5.44 8.93% | -6.46 18.64% | |
payables turnover | 0.00 - | 0.09 82,860.13% | 0.70 649.64% | 0.47 32.23% | 0.93 96.95% | 0.65 29.94% | 1.07 64.03% | |||||
receivables turnover | 0.51 - | 4.04 700.35% | 3.16 21.88% | 11.74 271.67% | 12.36 5.31% | 8.98 27.32% | 5.92 34.13% | |||||
research and ddevelopement to revenue | 1.38K - | 88.68 93.56% | 5.71 93.56% | 3.45 39.65% | 1.52 55.87% | 1.41 6.95% | 1.94 37.31% | 1.49 23.13% | ||||
return on tangible assets | -0.59 - | -0.30 48.62% | -0.26 13.85% | -0.45 74.76% | -0.99 117.96% | -0.36 63.48% | -0.42 15.64% | -0.12 71.86% | -0.34 186.14% | -0.53 56.54% | -0.47 10.19% | |
revenue per share | 0.00 - | 0.06 1,731.32% | 1.03 1,581.47% | 1.83 77.19% | 4.45 142.99% | 5.18 16.36% | 5.20 0.26% | 5.90 13.62% | ||||
roe | -0.70 - | -0.32 53.80% | -0.27 15.20% | -0.52 89.20% | -0.79 51.89% | -0.32 58.81% | -0.62 89.81% | -0.16 73.76% | -0.49 204.51% | -2.01 307.79% | -2.20 9.75% | |
roic | -0.59 - | -0.30 48.47% | -0.27 9.80% | -0.52 91.17% | -0.81 55.58% | -0.61 24.90% | -0.59 3.90% | -0.27 54.80% | -0.38 43.11% | -1.57 313.99% | -1.57 0.32% | |
sales general and administrative to revenue | 488.24 - | 38.25 92.17% | 2.48 93.52% | |||||||||
shareholders equity per share | 1.72 - | 6.43 273.01% | 14.44 124.50% | 11.97 17.08% | 9.03 24.56% | 12.23 35.44% | 11.56 5.54% | 18.97 64.19% | 13.61 28.27% | 5.04 62.95% | 3.74 25.72% | |
stock based compensation to revenue | 363.23 - | 26.04 92.83% | 1.56 94.03% | 0.79 49.18% | 0.32 59.99% | 0.30 5.59% | 0.36 20.15% | 0.31 13.22% | ||||
tangible asset value | 50.11M - | 184.94M 269.09% | 531.09M 187.16% | 473.97M 10.75% | 197.50M 58.33% | 435.28M 120.39% | 480.36M 10.36% | 978.86M 103.78% | 747.37M 23.65% | 147.98M 80.20% | 64.74M 56.25% | |
tangible book value per share | 1.72 - | 6.43 273.01% | 14.44 124.50% | 11.97 17.08% | 4.65 61.14% | 8.74 87.97% | 8.49 2.91% | 16.09 89.48% | 11.02 31.48% | 2.12 80.80% | 0.88 58.41% | |
working capital | 49.30M - | 174.97M 254.88% | 422.29M 141.35% | 437.85M 3.69% | 173.45M 60.39% | 447.64M 158.08% | 747.72M 67.03% | 1.11B 47.88% | 675.24M 38.93% | 622.69M 7.78% | 451.75M 27.45% |
All numbers in USD (except ratios and percentages)